What are the key takeaways from this Drug Story episode?

Key insights include: **Zolpidem gender dosing:** The FDA cut the recommended dose for women in half — from 10mg to 5mg — in 2013 after data showed zolpidem remained in women's bodies significantly longer than in men. Women accounted for two-thirds of zolpidem-related ER visits, which tripled between 2005 and 2010 as prescriptions rose post-patent expiration.; **Placebo effect benchmark:** When evaluating insomnia drugs, roughly 50% of placebo recipients report improved sleep without any active medication. Ambien's 10mg dose achieved ~90% positive response versus 51% for placebo — a meaningful but narrower gap than marketing implied. Understanding this helps patients critically evaluate any new sleep supplement or prescription claim.; **CBT-I over medication:** Cognitive Behavioral Therapy for Insomnia (CBT-I) is the current first-line recommended treatment by sleep medicine specialists because it addresses root behavioral causes rather than masking symptoms. Practical techniques include restricting time in bed to actual sleep duration and avoiding rewarding wakefulness with enjoyable activities like TV or snacking.

What did Andrew Crystal discuss on Drug Story?

Drug Story examines Ambien (zolpidem), the most prescribed sleeping pill in US history, through Caroline's firsthand account of sleepwalking, blackouts, and relationship damage, alongside psychiatrist Dr. Andrew Crystal's analysis of why insomnia treatment remains flawed and why Cognitive Behavioral Therapy outperforms medication for chronic sufferers. Key topics include: **Zolpidem gender dosing:** The FDA cut the recommended dose for women in half — from 10mg to 5mg — in 2013 after data showed zolpidem remained in women's bodies significantly longer than in men. Women accounted for two-thirds of zolpidem-related ER visits, which tripled between 2005 and 2010 as prescriptions rose post-patent expiration.; **Placebo effect benchmark:** When evaluating insomnia drugs, roughly 50% of placebo recipients report improved sleep without any active medication. Ambien's 10mg dose achieved ~90% positive response versus 51% for placebo — a meaningful but narrower gap than marketing implied. Understanding this helps patients critically evaluate any new sleep supplement or prescription claim..

How long is this episode of Drug Story?

This episode is 48 minutes long. SignalCast provides an AI-generated summary so you can get the key insights in about 3 minutes.

Drug Story

On Ambien and insomnia

March 3, 2026

48 min episode · 2 min read

Andrew Crystal

Episode

48 min

Read time

2 min

Topics

Health & Wellness, Relationships, Fundraising & VC

AI-Generated Summary

Published Mar 4, 2026

Key Takeaways

✓Zolpidem gender dosing: The FDA cut the recommended dose for women in half — from 10mg to 5mg — in 2013 after data showed zolpidem remained in women's bodies significantly longer than in men. Women accounted for two-thirds of zolpidem-related ER visits, which tripled between 2005 and 2010 as prescriptions rose post-patent expiration.
✓Placebo effect benchmark: When evaluating insomnia drugs, roughly 50% of placebo recipients report improved sleep without any active medication. Ambien's 10mg dose achieved ~90% positive response versus 51% for placebo — a meaningful but narrower gap than marketing implied. Understanding this helps patients critically evaluate any new sleep supplement or prescription claim.
✓CBT-I over medication: Cognitive Behavioral Therapy for Insomnia (CBT-I) is the current first-line recommended treatment by sleep medicine specialists because it addresses root behavioral causes rather than masking symptoms. Practical techniques include restricting time in bed to actual sleep duration and avoiding rewarding wakefulness with enjoyable activities like TV or snacking.
✓Sleep hygiene specifics: Dr. Crystal identifies concrete behaviors that worsen insomnia: exercising too close to bedtime, excessive caffeine, and spending extra time in bed hoping to accumulate sleep. Counterintuitively, consolidating sleep into one shorter, consistent window — rather than extending bed time — produces measurably better daytime functioning and subjective rest quality.
✓Trazodone prescribing paradox: Trazodone, an antidepressant with no FDA approval for insomnia and no strong clinical evidence supporting its use as a sleep aid, is currently the most prescribed drug for insomnia in the US. Both the American Academy of Sleep Medicine and the American Association of Family Physicians actively recommend against prescribing it for this purpose.

What It Covers

Drug Story examines Ambien (zolpidem), the most prescribed sleeping pill in US history, through Caroline's firsthand account of sleepwalking, blackouts, and relationship damage, alongside psychiatrist Dr. Andrew Crystal's analysis of why insomnia treatment remains flawed and why Cognitive Behavioral Therapy outperforms medication for chronic sufferers.

Key Questions Answered

•Zolpidem gender dosing: The FDA cut the recommended dose for women in half — from 10mg to 5mg — in 2013 after data showed zolpidem remained in women's bodies significantly longer than in men. Women accounted for two-thirds of zolpidem-related ER visits, which tripled between 2005 and 2010 as prescriptions rose post-patent expiration.
•Placebo effect benchmark: When evaluating insomnia drugs, roughly 50% of placebo recipients report improved sleep without any active medication. Ambien's 10mg dose achieved ~90% positive response versus 51% for placebo — a meaningful but narrower gap than marketing implied. Understanding this helps patients critically evaluate any new sleep supplement or prescription claim.
•CBT-I over medication: Cognitive Behavioral Therapy for Insomnia (CBT-I) is the current first-line recommended treatment by sleep medicine specialists because it addresses root behavioral causes rather than masking symptoms. Practical techniques include restricting time in bed to actual sleep duration and avoiding rewarding wakefulness with enjoyable activities like TV or snacking.
•Sleep hygiene specifics: Dr. Crystal identifies concrete behaviors that worsen insomnia: exercising too close to bedtime, excessive caffeine, and spending extra time in bed hoping to accumulate sleep. Counterintuitively, consolidating sleep into one shorter, consistent window — rather than extending bed time — produces measurably better daytime functioning and subjective rest quality.
•Trazodone prescribing paradox: Trazodone, an antidepressant with no FDA approval for insomnia and no strong clinical evidence supporting its use as a sleep aid, is currently the most prescribed drug for insomnia in the US. Both the American Academy of Sleep Medicine and the American Association of Family Physicians actively recommend against prescribing it for this purpose.

Notable Moment

Caroline's neighbor physically stopped her from getting into her car while she was in an Ambien-induced blackout state — an event she has no memory of. She continued taking the drug despite losing two relationships and alarming her mother, describing the psychological toll as feeling like a fundamentally bad person.

Know someone who'd find this useful?

Episode Transcript

Well, I I was single living on my own, and I would just lay in my bed in agony. And this was really before smartphones. But I would just lay there tossing and turning. Then, of course, I would look at the clock. This is Caroline. She has insomnia. I have lived my entire life in Columbus, Ohio, and I am 42 years old. I think many people have sort of described insomnia and the mental anguish it causes in this way that if I fall asleep now, I still have an opportunity to get six solid hours. And it gets to a point where once the clock whittles down to, you know, maybe four hours or you see the sunlight coming up, But then it's time for work, and you have to go into work just depleted, looking terrible, feeling terrible, and not on your game. But, of course, that night, you're thinking, I'm going to get a good night's sleep tonight, but then it just happens again. And do you remember that first night that you took an Ambien? Do you remember what that was like? You know, it's funny. I actually do. I had taken the dose maybe twenty minutes prior, and all of a sudden, the the laptop screen was wavy, and everything was great. Life was great. You couldn't say anything to get me down at that point. I was not full of energy. I was very mellowed out. I was happy. I was relaxed. It was a euphoria. That lasted maybe fifteen, twenty minutes before I was like, wow. I'm really tired. I slept better than I had in quite some time because the next day, I thought, I'm gonna sleep tonight because that medication was fantastic. But then Caroline started to notice strange things. I found myself, though, quickly waking up to pans and boxes of pasta that I had cooked and I did not remember. It progressed into making phone calls and texts that I didn't remember, and so that was a bit frightening. It impacted some romantic relationships that I was in. I had been seeing a man for around six months. I really liked him, and, he had ended the relationship because one night, I had taken an Ambien, and I apparently had said something, and I don't even know what I had said to him. And I had explained to him that Ambien can sometimes cause that, and he was, I guess, didn't believe it. Right. I mean, it sounds like there were very clear pros and cons to to taking this drug, that there were benefits that you you needed to sleep, but all these kind of side effects that were quite significant. Absolutely. And there was a time one instance one instance where I wanted to drive, and I don't wanna think about what would have happened because I don't even remember it. And my neighbor was there and stopped me. I just felt like a bad …

Get the full transcript (6,855 words) + summary by email — free

One-time email with the complete transcript and AI summary of this episode. No account needed.

One email, no spam. We’ll also show you what SignalCast does.

Browse all Drug Story transcripts →